Validations: Serialization, Aggregation & Supply-Chain Data Integrity

Training & Communication for Serialization Changes

Training & Communication for Serialization Changes Understanding Serialization and Its Regulatory Framework Serialization is a critical aspect of the pharmaceutical supply chain, ensuring that each individual unit of a prescription drug can be uniquely identified. This practice is not only a means of combating counterfeit products, but it also ensures compliance with regulations established by various authorities, including the FDA…

Continue Reading Training & Communication for Serialization Changes

CPV Signals from Serialization: KPIs after Change

CPV Signals from Serialization: KPIs after Change Serialization has transformed the pharmaceutical supply chain landscape, ensuring enhanced track and trace capabilities, compliance with regulatory requirements, and robust data integrity. In the context of controlled processes and testing methodologies, it is imperative to monitor Critical Process Variables (CPV) and identify Key Performance Indicators (KPIs) that signal effective compliance and operational efficiency,…

Continue Reading CPV Signals from Serialization: KPIs after Change

Rollback Plans: When and How to Use Them

Rollback Plans: When and How to Use Them Rollback Plans: When and How to Use Them Understanding Rollback Plans in the Context of Serialization Rollback plans are a crucial part of a structured approach to serialization, especially within the pharmaceutical industry. With the growing emphasis on data integrity and regulatory compliance, rollback plans ensure that organizations have clear strategies in…

Continue Reading Rollback Plans: When and How to Use Them

Storyboards for Serialization Change Decisions

Storyboards for Serialization Change Decisions Storyboards for Serialization Change Decisions The serialization of pharmaceutical products has become a critical component of ensuring supply chain integrity and compliance with various regulatory frameworks, including the Drug Supply Chain Security Act (DSCSA) in the United States and the EU Falsified Medicines Directive (FMD) in Europe. Implementing effective serialization and aggregation systems requires rigorous…

Continue Reading Storyboards for Serialization Change Decisions

Inspection Readiness for Serialization Changes

Inspection Readiness for Serialization Changes Inspection Readiness for Serialization Changes Serialization has become a critical focus for pharmaceutical companies worldwide due to various regulatory requirements, including the Drug Supply Chain Security Act (DSCSA) in the U.S. and the EU Falsified Medicines Directive (FMD). As the industry continuously evolves, understanding the readiness for serialization changes is essential for maintaining compliance and…

Continue Reading Inspection Readiness for Serialization Changes

Reconciliation Rule Changes: Guardrails and Justification

Reconciliation Rule Changes: Guardrails and Justification Reconciliation Rule Changes: Guardrails and Justification This article aims to provide a comprehensive step-by-step guide to understanding reconciliation rule changes in the context of serialization and aggregation processes in the pharmaceutical sector. As regulatory landscapes evolve with the DSCSA, EU FMD requirements, and the need for robust data integrity protocols, the importance of compliance…

Continue Reading Reconciliation Rule Changes: Guardrails and Justification

Artwork/Label Changes: Cross-Checks and Tests

Artwork/Label Changes: Cross-Checks and Tests Introduction to Serialization and Aggregation in Pharmaceuticals In the pharmaceutical industry, ensuring the integrity and compliance of product serialization and aggregation processes is paramount. Serialization involves unique identification of each saleable unit, while aggregation refers to the hierarchical organization of products into groups, such as bundles and pallets. With regulatory frameworks like the US Drug…

Continue Reading Artwork/Label Changes: Cross-Checks and Tests

Country Rule Changes: US DSCSA, EU FMD, and Others

Country Rule Changes: US DSCSA, EU FMD, and Others Country Rule Changes: US DSCSA, EU FMD, and Others Introduction to Serialization Regulations The pharmaceutical industry operates under stringent regulations to ensure the safety and integrity of drugs from manufacturing to patient administration. Among these regulations, serialization plays a critical role in tracking and tracing products throughout the supply chain. Recently,…

Continue Reading Country Rule Changes: US DSCSA, EU FMD, and Others

Cloud/SaaS Changes: Shared Responsibility Evidence

Cloud/SaaS Changes: Shared Responsibility Evidence Cloud/SaaS Changes: Shared Responsibility Evidence The implementation of Cloud and Software as a Service (SaaS) solutions in the pharmaceutical industry has fundamentally changed the way serialization and aggregation systems operate. As companies navigate these technologies, ensuring compliance with regulations such as the US FDA’s Drug Supply Chain Security Act (DSCSA) and the European Union Falsified…

Continue Reading Cloud/SaaS Changes: Shared Responsibility Evidence

Security Changes: Certificates, Keys, and Access

Security Changes: Certificates, Keys, and Access Security Changes: Certificates, Keys, and Access – A Comprehensive Guide for Pharmaceutical Professionals Understanding the Regulatory Landscape for Serialization and Change Control In today’s pharmaceutical environment, ensuring compliance with serialization requirements is paramount for maintaining data integrity across the supply chain. Regulatory bodies such as the FDA, EMA, and MHRA have established stringent regulations…

Continue Reading Security Changes: Certificates, Keys, and Access